Építés alatt – nem éles oldal
Belépés
Toborzás még nem indultFázis nélkül

FMT for Insomnia Disorder (FMT-SLEEP)

A legfontosabb adatok

Ki végzi
Chinese University of Hong Kong
Hol
Hongkong1 helyszín, 1 országbanVálassz országot a helyszínekhez
Azonosító
Állapot
Toborzás még nem indult
Résztvevők
74 fő, tervezett
Kezdés
2024. nov. 1.
Várható befejezés
2027. ápr. 30.
A vizsgálat típusa
Beavatkozással járó, 2 csoportAz egyik csoport színlelt kezelést kap, összehasonlításként.
A vizsgált kezelések
  • Faecal Microbiota Transplantation
  • Normal Saline (Placebo)
A regiszteradat frissítve
2024. szeptember 23.

Ki vehet részt

MI-összefoglaló

A vizsgálat saját részvételi feltételeiből. Gép olvasta ki az oldalon álló regiszterszövegből, ezért tévedhet. Hogy ki vehet részt, azt a lenti regiszterszöveg és a vizsgálat csapata dönti el.

The trial is looking for adults with long-term (chronic) insomnia. It tests faecal microbiota transplantation (stool from healthy donors put into the gut) against a salt-water placebo.

Életkor
18 years and older
Nem
All sexes
A betegség stádiuma
Chronic insomnia disorder diagnosed by DSM-5 criteria, moderate or worse, with an ISI (Insomnia Severity Index) score above 14.
Korábbi kezelés
No change in insomnia treatment or therapy within 4 weeks. No antibiotics, probiotics or prebiotics within 4 weeks.

A részvétel fő kizáró okai

  • Another sleep disorder that disrupts sleep, such as restless legs syndrome or circadian rhythm sleep disorder, or doing shift work
  • Needing urgent psychiatric care, or a suicide attempt in the past 6 months
  • Severe organ failure, kidney failure on dialysis, HIV infection, or active cancer
  • Past abdominal surgery, or reasons you cannot have a GI endoscopy (a camera test of the gut)
  • Known pregnancy, being in another interventional study, or being unable to give consent

A regiszter feltételei, szó szerint

Mind a 14 feltétel megnézéseKevesebb

Ki vehet részt

  • 1. Individuals aged 18 and above
  • 2. Subjects who were diagnosed with chronic insomnia disorder according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and with moderate or above insomnia disorder defined as ISI > 14

Ki nem vehet részt

  • 3. Change of treatment or therapy for insomnia within 4 weeks
  • 6. Had abdominal surgery
  • 1. Having an additional sleep disorder, such as restless legs syndrome, or circadian rhythm sleep disorder, that can significantly disrupt the sleep cycle as ascertained by Diagnostic Interview for Sleep Patterns and Disorders (DISP)
  • 2. Requiring immediate psychiatric care (e.g., imminently suicidal subjects) or have attempted suicide in the past 6 months
  • 4. Known history of severe organ failure (including decompensated cirrhosis), renal failure on dialysis, suffering from human immunodeficiency virus infection
  • 5. Confirmed active malignancy
  • 7. Contraindications to GI endoscopy
  • 8. On shift work
  • 9. Taking antibiotics, probiotic or prebiotic preparations within 4 weeks
  • 10. Known pregnancy
  • 11. Mental retardation or inability to provide informed consent
  • 12. Are participating in other interventional studies

Hol van ez a vizsgálat?

Egy országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.

A vizsgálatról

Mit akar kideríteni a vizsgálat

Insomnia disorder is characterized by difficulty initiating or maintaining sleep, or early morning awakening accompanied by symptoms such as irritability or fatigue during wakefulness. It is one of the most prevalent health concerns in the population and in clinical practice, with more than one-third of adults experience transient insomnia at some point in their lives. In about 40% of cases, insomnia can develop into a more chronic condition. The COVID-19 pandemic has further aggravated sleep problems, with a reported global prevalence of sleep disturbances reaching 40-49%. The implications of insomnia disorder are substantial, encompassing social, economic, psychological, and physical aspects.

A teljes eredeti leírásKevesebb

Behavioural, cognitive, and pharmacological interventions can all be effective for insomnia. Pharmacological treatment is commonly used but may have drawbacks such as adverse events and inconclusive safety data for certain medications. Many licensed drugs can be effective in the acute treatment of insomnia but are associated with poor tolerability, or information about long-term effects is not available. Alternatively, cognitive behavioural therapy for insomnia (CBT-I), has been recommended as the first-line treatment for chronic insomnia in adults of any age according to the American and European guidelines. But issue of accessibility, compliance/adherence, and moderate response limit the practicality and applicability of CBT-I.

Recent evidence suggests that the gut microbiota plays a role in regulating sleep behaviour, both directly and indirectly. This has led to the exploration of gut microbiota modulation as a potential therapy for insomnia. Faecal microbiota transplantation (FMT), which is the infusion of faeces from healthy donors to the gut of affected subjects, has shown impressive therapeutic effects for various diseases. Several real-world studies have demonstrated improvements in symptoms of insomnia disorder following FMT. One previous study also indicated the potential of FMT in alleviating post-COVID insomnia. In this randomised, double-blind, placebo-controlled trial, the investigators aim to assess the efficacy of FMT in improving insomnia disorder. Two groups will be recruited in 1:1 ratio. The intervention group will receive FMT while the control group will receive normal saline as placebo. Both groups will have the same assessments.

A vizsgálat 2 csoportja

  • Faecal Microbiota TransplantationA vizsgált kezelés

    FMT will be reconstituted from healthy donor's stool

  • PlaceboSzínlelt kezelés, összehasonlításként

    Subjects will receive 0.9% sodium chloride solution (normal saline) as placebo identical looking with FMT

    Kezelés: Normal Saline (Placebo)

Kérdések a vizsgálat csapatának

  1. Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
  2. Megtérítik az utazási költséget?
  3. Megtarthatom a saját orvosomat?
  4. Mi történik, ha ki akarok lépni?

Contact the study team: see the registry record → Contacts and Locations

Oldal nyomtatása az orvosomnak

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
Faecal Microbiota Transplantation for Insomnia Disorder: a Randomized, Double-blind, Placebo-controlled Trial
MI-összefoglaló
A vizsgálat saját részvételi feltételeiből. Gépi kiolvasás: 2026. november 14.
A regiszteradat frissítve
2024. szeptember 23.